Supplementary Figure 2 from Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 2
Authors: Shiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, Xiaoyang Ling, Cynthia Kassab, Pinaki Banerjee, Mustafa Bdiwi, Hila Shaim, Abdullah Alsuliman, Mayra Shanley, John F. de Groot, Barbara J. O'Brien, Rebecca Harrison, Nazanin Majd, Carlos Kamiya-Matsuoka, Gregory N. Fuller, Jason T. Huse, Linda Chi, Ganesh Rao, Jeffrey S. Weinberg, Frederick F. Lang, Raymond Sawaya, Elizabeth J. Shpall, Katayoun Rezvani, Amy B. Heimberger
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362137774
